Halo logo
Marketplace
For Industry Partners
For Innovators
Contact sales
Sign in
Join now
All startup programs
Bayer Pharma
Co.Lab Berlin
Startup program
In-person
Accepts up to 5 startups
No initial funding
0% equity
2 years
  • Background
  • What we're looking for
  • What we can offer you
  • Who we are
  • Q&A

Leverage Bayer's competencies, expertise, network, and laboratory infrastructure in order to bring your brilliant ideas to life—with no strings attached.

Background

At Bayer, we’re always looking to support new technologies and creative approaches to develop more effective treatments for diseases. If you’re an early-stage life science start-up company with that next great idea, then Bayer Co.Lab incubators can offer you the dynamic atmosphere you need to succeed. You’ll be part of a global community of entrepreneurs with opportunities to grow your company while exploring new ideas. Access to Bayer’s global research, development, and manufacturing expertise will give you the power and technology to take your ideas all the way to patients. We can’t wait to be a part of your journey! Bayer’s Co.Lab Berlin is specifically designed to support cutting-edge cell and gene therapies (CGT) and oncology entrepreneurs with access to Bayer’s enterprise-wide expertise in addition to state-of-the art laboratory and office space.

Accepting applications from startups based in all countries and who are willing to move entirely or part of their research activities to Berlin to benefit from the offering.

The space will be available starting in October 2024, but startups can take up residence after that point if needed, too. We offer two years of residence, with the possibility for an additional year extension. We are not able to sponsor visas.

What we're looking for

Areas of interest
We're interested in startups focused on areas including:
  • Cell therapy
  • Gene therapy
  • Gene delivery
  • RNA therapeutics
  • Oncology – small molecules/biologics/novel modalities
  • Oncology – novel targets
Startup location
  • Accepting applications from startups based in all countries
Stage of funding
We're looking for startups at the following stages:
  • Pre-seed
  • Seed
  • Series A
Acceptable technology readiness levels (TRL)
We're looking for startups with solutions in the following TRL range:
Levels 3-7
What we can offer you
Benefits:
Facilities and Services
Spacious, equipped yet customizable lab and office space with shared equipment to reduce capital expenditures with flexible leasing agreements. Make use of the competitive usage fees offered by Bayer Co.Lab in the heart of Berlin. Benefit from additional offerings on the campus, from canteen and coffee shop to dry-cleaning service and gym.
Networking
Co-locate and build relationships with multiple groups at Bayer’s Pharma headquarters. Get immersed in the Bayer Co.Lab startup ecosystem in the heart of Berlin and become a part of the Start Up community of Bayer Co.Labs globally. Benefit from Bayer’s efforts to connect with other Ecosystem players and partners in Germany and Europe.
Expertise
Company-tailored specific mentoring program; regular & on-demand touchpoints with Bayer experts, who provide continuous insights regarding key issues, such as manufacturing; and early access to leadership and technology.
Who we are

Bayer Co.Lab is a growing global network of life science incubators that provides entrepreneurs and early-stage companies access to state-of-the-art facilities, resources, and expertise with no strings attached. At Co.Lab, we take a high-touch, tailored approach to support our resident companies.

Beyond Berlin, our Co.Labs are spread over multiple locations in Boston, USA, Kobe in Japan and our global foot print is expanding to include launching our site in Shanghai, China.

Reviewers
SI
Sara Ibrahim
Co.Lab Strategy and Portfolio Manager
SC
Simon Cladders
Director Portfolio Strategy & Operations
RS
Ruth Shah
Head of Bayer Co.Lab Berlin
AN
Alberto Nobili
VP, Head of Co.Lab Cambridge
Q&A with Bayer Pharma

The Q&A is now closed.

Sort by:
Q.
Is it a shared lab and office space?
EG
Erwin Gorjup, Chief Scientific Officer & Co-Founder, Sarcura
May 29, 2024
1
A.
Dear Erwin, the labs are seperated which allows each Start Up to work individually and independently on their work. Larger equipment are placed in a common lab space that allows some exchange betwwen start ups The office space (on the same floor as the labs) is open and allows a dynamic working environment and more synnergies between residents. Berlin Co.Lab also includes meeting rooms and phone booths for holding team meetings and having online meetings, both options can be booked by team members of the Start Ups
SI
Sara Ibrahim, Co.Lab Strategy and Portfolio Manager , Bayer Pharma
May 30, 2024
Is this response helpful?
0
0
Q.
Could you elaborate on the expectations re. our team size in Berlin?
EG
Erwin Gorjup, Chief Scientific Officer & Co-Founder, Sarcura
May 29, 2024
1
A.
Dear Erwin, Thank you for your question! the team that could move into the Co.Lab in Berlin can be up to 10 team members (which corresponds to the space availalbity in our Berlin location), but a smalle rteam is also welcomed of course
SI
Sara Ibrahim, Co.Lab Strategy and Portfolio Manager , Bayer Pharma
May 30, 2024
Is this response helpful?
0
0
Q.
Can you elaborate on the lab equipment available? Does it include biological safety labs?
EG
Erwin Gorjup, Chief Scientific Officer & Co-Founder, Sarcura
May 29, 2024
1
A.
The labs are Bio.Safety level 1 and BSL 2, each lab includes space for up to six benches, two cell culture benches, incubators, centrifuges and more. in the common lab space there will be larger equipment to be shared by Start ups: Autoclave, FACS, microscopes, plate reader, PCR and more
SI
Sara Ibrahim, Co.Lab Strategy and Portfolio Manager , Bayer Pharma
May 30, 2024
Is this response helpful?
0
0
Q.
Does the startup program offer stipends to cover employee salaries?
DH
Dejan Husman, CEO, MatriSys Bioscience
June 26, 2024
1
A.
Dear Dejan, thank you for your question, at the moment a stipend is not planned as part of Co.Lab's offering
SI
Sara Ibrahim, Co.Lab Strategy and Portfolio Manager , Bayer Pharma
July 1, 2024
Is this response helpful?
0
0
Q.
Could you explain the oncology focus in greater detail? Do applying startups have to be working on a drug molecule or biomarker directly, or are enabling technologies also considered?
DH
Dejan Husman, CEO, MatriSys Bioscience
June 26, 2024
1
A.
Dear Dejan, any asset in Oncology will be considered (even small molecules or antibodies), enabling technologies & platforms would be also considered upon application and assessed by experts to determine the scope
SI
Sara Ibrahim, Co.Lab Strategy and Portfolio Manager , Bayer Pharma
July 1, 2024
Is this response helpful?
0
0
Q.
What is the length of time that startups are incubated for? Is there something like a demo day at the end of the incubation period for connecting with investors?
DH
Dejan Husman, CEO, MatriSys Bioscience
June 26, 2024
1
A.
Dear Dejan, the residency is lanned for a period of 2 years that could be extended for more additional year upon review and agreement by the Co.Lab and the Start Up. During the residency, threre will be plans to hold events to connect with potential VCs.
SI
Sara Ibrahim, Co.Lab Strategy and Portfolio Manager , Bayer Pharma
July 1, 2024
Is this response helpful?
0
0
Sign up to access the full partnering request.
View the details of this request and connect directly with corporate R&D teams at Fortune 500 companies.
Stay in the loop
 2 
finalists selected
Refine recommendations
Is this request relevant to you?

In-Person Locations

Berlin, Germany

Eligible partners
Startups
Seeking partners focused on
OncologyGene TherapyCell TherapyBiotechnology
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
Company
AboutBlogCareersHalo Awards
Support
FAQsHelp center
Contact us
Sponsors
Customer stories
Privacy PolicyTerms of Service
© 2026 Halo Cures, Inc.